Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2018

01-08-2018 | Letter to the Editor

Design and Interpretation of Noninferiority Trials

Authors: Scott K. Aberegg, MD, MPH, Andrew M. Hersh, MD

Published in: Journal of General Internal Medicine | Issue 8/2018

Login to get access

Excerpt

Authors’ reply: We are grateful for the correspondents’ interest in our descriptive study of noninferiority trials.1 Turgeon et al. have retrospectively extended the part of our analysis comparing ITT (intention-to-treat) and PP (per-protocol) methodologies to 2004. While we found that 64% of trials in our cohort from 2011 to 2016 reported both ITT and PP analyses, they found that only 45% of trials in the same journals between 2004 and 2014 reported both analyses. These results are consistent with those found in other reports, with modest increases over time in the reporting of both analyses.24 Regarding discordant results between analyses, both of our results reinforce the observation that the theoretical claim that PP analyses are more conservative than ITT analyses is empirically ungrounded. Ideally, both PP and ITT methodologies should be carefully described and reported with an a priori plan for handling discordant results when they occur. …
Literature
Metadata
Title
Design and Interpretation of Noninferiority Trials
Authors
Scott K. Aberegg, MD, MPH
Andrew M. Hersh, MD
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4505-8

Other articles of this Issue 8/2018

Journal of General Internal Medicine 8/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.